cdc25 inhibitors (Taiho)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecdc25 inhibitors (Taiho)
Drug Alias Namedysidiolide derivatives (Taiho/Nara Inst/Tokyo University)TPY-647TPY-835
ClassificationSmall molecules
Mechanisms of ActionCell division cycle 25 phosphatase inhibitorsCell cycle inhibitors
TargetsCell division cycle 25 phosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A